World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   8046 records for 1339 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingISRCTN10628521
Theory based oral hygiene intervention in adolescents
07/08/2015
AuthorisedEUCTR2015-000424-28-ES
A study to assess the efficacy and safety of tocilizumab versus placebo in patients with Systemic Sclerosis.
04/08/2015
Not recruitingNCT02519426
Clinical Validation of a Novel Classification for Predicting Surgical Complexity in Mandibular Wisdom Teeth Surgery
03/08/2015
RecruitingNCT02483273
Alterations of Conjunctival Microcirculation in Brain Dead Patients
18/06/2015
AuthorisedEUCTR2014-005338-74-LT
To find out whether LFG316 is able to reduce the destruction of red blood cells in patients with PNH
09/06/2015
AuthorisedEUCTR2015-001747-37-HU
A single-dose study to asses the efficacy and safety of palonosetron administered as 30-minute infusion compared to palonosetron administered as a 30-second injection for preventing chemotherapy-induced nausea and vomiting in cancer patients.
08/06/2015
AuthorisedEUCTR2014-003997-18-LT
A study investigating Immune Globuline (Human), 10% Caprylate/Chromatography Purified (IGIV-C) for the treatment of patients with Myasthenia Gravis. The patients will receive 2g/kg of IP as a loading dose. The loading dosage is followed by maintenance doses of 1 g/kg administered every third week until Visit 8 (Week 21). 25/05/2015
AuthorisedEUCTR2013-005099-17-LT
A study investigating Immune Globuline (Human), 10% Caprylate/Chromatography Purified (IGIV-C) for the treatment of patients with Myasthenia Gravis, dependent on Corticosteroids. The patients will receive 2g/kg of IP as a loading dose. The loading dosage is followed by maintenance doses of 1 g/kg administered every third week until Visit 13 (Week 36). During maintenance doses the investigator will try to slowly reduce the patient's corticosteroid dose. 25/05/2015
AuthorisedEUCTR2015-000050-38-LT
Study to demonstrate the efficacy (including inhibition of structural damage), safety and tolerability up to 2 years of secukinumab in Active Psoriatic Arthritis 25/05/2015
Not recruitingNCT02453256
A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc) [focuSSced]
21/05/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history